US FDA's Decisions On 'Article' As Dietary Or Drug Ingredient: Level Playing Field?
Executive Summary
FDA drug center could hold more sway over which ingredients are allowed for use in supplements than center regulating supplement industry, suggests CRN CEO Steve Mister at a recent regulatory conference. ODSP second-in-command Gregory Noonan allows that agency has “vague” rule for “article” used in a supplement or a drug.